Stock Updates

Morning Top Movers: AstraZeneca PLC (NYSE: AZN)

With a market cap of 87.64 B, AstraZeneca PLC has a large market cap size. AstraZeneca PLC (NYSE: AZN) has been on the stock market since its IPO date on the 5/17/1993. AstraZeneca PLC is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for AstraZeneca PLC, is 4103.02, and so far today it has a volume of 3950082. Performance year to date since the 5/17/1993 is 26.79%.

To help you determine whether AstraZeneca PLC is undervalued the following values will help you decide. P/E is 25.87 and forward P/E is 17.56. PEG perhaps more useful shows that AstraZeneca PLC has a value for PEG of 3.54. P/S ratio is 3.93 and the P/B ratio is 6.75. The P/Cash and P/Free cash flow is 23.95 and *TBA respectively.

At the current price AstraZeneca PLC is trading at, 34.64 (0.29% today), AstraZeneca PLC has a dividend yield of 5.48%, and this is covered by a payout ratio of 102.70%. Earnings per share (EPS) is 1.34, and this is looking to grow in the next year to 6.08% after growing 23.80% this past year. EPS growth quarter over quarter is -16.90%, and -11.60% for sales growth quarter over quarter.

The number of shares outstanding is 2530, and the number of shares float is 2503.68. The senior management bring insider ownership to 0.50%, and institutional ownership is at 14.90%. The float short is 1.11%, with the short ratio at a value of 6.78. Management has seen a return on assets of 5.40%, and also a return on investment of 15.00%.

The ability for AstraZeneca PLC, to deal with debt, means it current ratio is 0.8, and quick ratio is 0.6. Long term debt/equity is 1.12 and total debt/equity is 1.34. In terms of margins, AstraZeneca PLC has a gross margin of 82.70%, with its operating margin at 21.40%, and AstraZeneca PLC has a profit margin of 15.20%.

The 52 week high is -1.79%, with 35.58% being its 52 week low. The 20 day simple moving average is 0.74% and the 200 day simple moving average is 14.78%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 

About the author

Peter Clarke

Leave a Comment